PatrickOhMD

Physician

Dr. Oh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterResidency, Radiation Oncology, 2021 - 2025
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 2020 - 2021
Stony Brook University Health Sciences Center School of MedicineClass of 2020, MD
Duke UniversityBS, Biology, High Distinction, 2011 - 2015

Journal Articles

Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain- Dependent Manner in Mice
Daniel, AR, Lee, CL, Oh, P, Luo, L, Ma, Y, Kirsch, DG, Health Physics, 3/14/2020
Deletion of ATM in tumor but not endothelial cells improves radiation response in a primary mouse model of lung adenocarcinoma
Torok JA*, Oh P*, Castle, KD, Reinsvold M, Luo L, Lee CL, Kirsch DG, Cancer Research, 10/12/2018
Blocking cyclin-dependent kinase 4/6 during single dose vs. fractionated radiation therapy leads to opposite effects on acute gastrointestinal toxicity in mice
Lee CL, Oh P, Xu E, Ma Y, Kim Y, Daniel AR, Kirsch DG, International Journal of Radiation Oncology, Biology, Physics, 12/1/2018
Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy
Moding EJ, Castle KD, Perez BA, Oh P, Min HD, Norris H, Ma Y, Cardona DM, Lee CL, Kirsch DG, Science Translational Medicine, 3/11/2015
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium
Moding EJ, Lee CL, Castle KD, Oh P, Mao L, Zha S, Min HD, Ma Y, Das S, Kirsch DG, Journal of Clinical Investigation, 7/18/2014
Join now to see all

Abstracts/Posters

Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
Oh P, Zhang M, Brady P, Sihag S, Molena D, Ilson DH, Janjigian YY, Ku GY, Wu AJ, Journal of Clinical Oncology, 2/26/2018
Impact of lung and heart dose on survival after radiotherapy for esophageal cancer
Oh P, Zhang M, Brady P, Yorke E, Won E, Goodman KA, Wu AJ, Journal of Clinical Oncology, 2/26/2018
Lack of validation of lymphopenia as a prognostic factor in esophageal cancer chemoradiation
Zhang M, Oh P, Brady P, Ilson DH, Janjigian Y,Ku G, Crane CH, Jackson A, International Journal of Radiation Oncology, Biology, Physics, 11/1/2018
Tumor cells, but not endothelial cells, mediate the eradication of primary cancers by radiation therapy
Moding EJ, Lee CL, Castle KD, Oh P, Kirsch DG, Cancer Research, 10/2014
Using Mouse Genetics to Dissect the Radiobiology of SBRT: Tumor Cells, Not Endothelial Cells, Regulate Local Control
Moding EJ, Lee, CL, Castle KD, Oh P, Kirsch DG, International Journal of Radiation Oncology, Biology, Physics, 9/1/2014
Dual Recombinase Technology Defines a Therapeutic Window for ATM Inhibitors to Selectively Radiosensitize Tumors
Moding EJ, Lee, CL, Castle KD, Oh P, Kirsch DG, International Journal of Radiation Oncology, Biology, Physics, 9/1/2014
Join now to see all

Studies Explore Colon Tumor Sidedness, Lung Radiation Dose in Esophageal Cancer, Pembrolizumab in Liver Cancer, and MoreMay 25th, 2020
In Esophageal Cancer, Lung Radiation Dose Affects SurvivalMay 25th, 2020